Rep. Jefferson Shreve Sells Agilent Technologies, Inc. (NYSE:A) Shares

Representative Jefferson Shreve (R-Indiana) recently sold shares of Agilent Technologies, Inc. (NYSE:A). In a filing disclosed on April 11th, the Representative disclosed that they had sold between $15,001 and $50,000 in Agilent Technologies stock on March 13th. The trade occurred in the Representative’s “CRT – STANDARD UNIT TRUST” account.

Representative Jefferson Shreve also recently made the following trade(s):

• Purchased $15,001 – $50,000 in shares of Harley-Davidson (NYSE:HOG) on 3/31/2025.
• Purchased $50,001 – $100,000 in shares of Block (NYSE:XYZ) on 3/31/2025.
• Sold $15,001 – $50,000 in shares of DuPont de Nemours (NYSE:DD) on 3/31/2025.
• Purchased $15,001 – $50,000 in shares of United Community Banks (NASDAQ:UCB) on 3/31/2025.
• Sold $15,001 – $50,000 in shares of IDEX (NYSE:IEX) on 3/31/2025.
• Purchased $15,001 – $50,000 in shares of HNI (NYSE:HNI) on 3/31/2025.
• Sold $50,001 – $100,000 in shares of ServiceNow (NYSE:NOW) on 3/31/2025.
• Sold $15,001 – $50,000 in shares of Coinbase Global (NASDAQ:COIN) on 3/31/2025.
• Sold $15,001 – $50,000 in shares of Constellation Energy (NASDAQ:CEG) on 3/31/2025.
• Sold $50,001 – $100,000 in shares of Simon Property Group (NYSE:SPG) on 3/31/2025.

Agilent Technologies Stock Performance

Shares of A stock traded down $2.13 during trading hours on Tuesday, reaching $103.06. The company had a trading volume of 1,326,712 shares, compared to its average volume of 1,858,075. The firm has a market cap of $29.38 billion, a PE ratio of 23.69, a price-to-earnings-growth ratio of 2.89 and a beta of 1.19. The business has a fifty day moving average price of $122.01 and a 200-day moving average price of $133.33. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $155.35. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.66 and a current ratio of 2.20.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, topping the consensus estimate of $1.27 by $0.04. The company had revenue of $1.68 billion during the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. Sell-side analysts predict that Agilent Technologies, Inc. will post 5.55 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be issued a $0.248 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $0.99 annualized dividend and a yield of 0.96%. Agilent Technologies’s payout ratio is 22.76%.

Institutional Trading of Agilent Technologies

A number of institutional investors have recently bought and sold shares of A. Norges Bank bought a new position in Agilent Technologies in the 4th quarter valued at $456,963,000. Madison Investment Advisors LLC bought a new stake in Agilent Technologies during the 4th quarter valued at about $94,051,000. GAMMA Investing LLC boosted its position in Agilent Technologies by 15,648.1% in the 1st quarter. GAMMA Investing LLC now owns 627,247 shares of the medical research company’s stock valued at $73,375,000 after buying an additional 623,264 shares during the period. Two Sigma Investments LP grew its stake in Agilent Technologies by 345.9% in the 4th quarter. Two Sigma Investments LP now owns 769,897 shares of the medical research company’s stock worth $103,428,000 after acquiring an additional 597,249 shares in the last quarter. Finally, Iron Triangle Partners LP purchased a new position in shares of Agilent Technologies during the fourth quarter worth approximately $80,110,000.

Insider Activity

In other Agilent Technologies news, Director Daniel K. Podolsky sold 1,819 shares of the company’s stock in a transaction on Monday, March 31st. The stock was sold at an average price of $116.46, for a total transaction of $211,840.74. Following the completion of the sale, the director now owns 35,737 shares in the company, valued at $4,161,931.02. This represents a 4.84 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Rodney Gonsalves sold 1,908 shares of the business’s stock in a transaction on Monday, March 17th. The stock was sold at an average price of $121.98, for a total value of $232,737.84. Following the completion of the transaction, the vice president now directly owns 21,786 shares of the company’s stock, valued at approximately $2,657,456.28. The trade was a 8.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 5,638 shares of company stock valued at $731,229.

Analyst Upgrades and Downgrades

A has been the subject of several analyst reports. Citigroup upped their price objective on Agilent Technologies to $165.00 and gave the stock a “buy” rating in a research note on Thursday, December 19th. Robert W. Baird lowered their price target on shares of Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating on the stock in a report on Thursday, February 27th. StockNews.com upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Tuesday, December 24th. Barclays lowered their price objective on Agilent Technologies from $138.00 to $115.00 and set an “equal weight” rating on the stock in a research report on Thursday, April 10th. Finally, TD Cowen increased their price objective on shares of Agilent Technologies to $135.00 and gave the company a “buy” rating in a report on Thursday, April 10th. Seven research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to MarketBeat, Agilent Technologies presently has a consensus rating of “Moderate Buy” and an average price target of $146.25.

About Representative Shreve

Jefferson Shreve (Republican Party) is a member of the U.S. House, representing Indiana’s 6th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Shreve (Republican Party) is running for re-election to the U.S. House to represent Indiana’s 6th Congressional District. He declared candidacy for the 2026 election.

Email [email protected] to notify us of updates to this biography.
Jefferson Shreve earned a bachelor’s degree from Indiana University in 1989, a graduate degree from the University of London in 1998, and a graduate degree from Purdue University in 2003. Shreve’s career experience includes working as a real estate executive.

Shreve was elected 7th District Vice Chairman of the Indiana Republican State Committee on January 17, 2018, and was re-elected on March 6, 2021. In 2020, he was selected as a district-level delegate to the 2020 Republican National Convention.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.